StayHappi Metformin+Voglibose 500mg/0.2mg Tablet
Marketer
Sarvagunaushdhi Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.2mg)
Overview StayHappi Metformin+Voglibose 500mg/0.2mg Tablet
StayHappi Metformin/Voglibose 500mg/0.2mg tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. This combination helps regulate blood glucose. Always take this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue this treatment even if feeling well or if blood sugar is controlled; discontinuation without medical advice risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, it's one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Potential side effects include nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes – generally transient and self-limiting. Persistent or concerning side effects warrant medical consultation. Your doctor can offer management strategies. This medication is unsuitable for type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding individuals must consult their doctor prior to use. Regular blood sugar monitoring, along with potential blood tests to track blood cell counts and liver function, are necessary.
Primary Ingredients of StayHappi Metformin+Voglibose 500mg/0.2mg Tablet
The provided text is "undefined," therefore no rewriting is possible.
Uses of StayHappi Metformin+Voglibose 500mg/0.2mg Tablet
Managing Type 2 Diabetes
Major Benefits of StayHappi Metformin+Voglibose 500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The StayHappi Metformin+Voglibose 500mg/0.2mg Tablet should be administered with a meal.
Common Side effects of StayHappi Metformin+Voglibose 500mg/0.2mg Tablet:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use StayHappi Metformin+Voglibose 500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consume StayHappi Metformin+Voglibose 500mg/0.2mg tablets with a meal.
How StayHappi Metformin+Voglibose 500mg/0.2mg Tablet works:
Duo-Diabetic 500/0.2mg tablets, containing metformin and voglibose, offer a dual-action approach to blood sugar management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking StayHappi Metformin+Voglibose 500mg/0.2mg Tablet is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of StayHappi Metformin+Voglibose 500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of StayHappi Metformin+Voglibose 500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by StayHappi Metformin+Voglibose 500mg/0.2mg Tablets. Nevertheless, patients using this medication concurrently with other diabetes treatments like sulfonylureas, insulin, or repaglinide should be aware of the potential for low blood sugar.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using StayHappi Metformin+Voglibose 500mg/0.2mg Tablets, as dosage modification may be necessary. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of kidney function is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of StayHappi Metformin/Voglibose 500mg/0.2mg tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take StayHappi Metformin+Voglibose 500mg/0.2mg Tablet :
Should you forget a StayHappi Metformin+Voglibose 500mg/0.2mg Tablet dose, take it immediately if remembered. However, near the time for your next scheduled dose, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About StayHappi Metformin+Voglibose 500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |
3,018 People bought this recently